Kłosiewicz-Latoszek L, Nowicka G, Szostak W B
Zakładu Zywienia Kliniczego Instytutu Zywności i Zywienia w Warszawie.
Wiad Lek. 1993 Aug;46(15-16):581-5.
In 20 men with hypercholesterolaemia or mixed hyperlipaemia the effect was evaluated of treatment with Lovastatin and Colestipol on lipoproteins. Administration of the drugs in combination or alone decreased significantly the concentrations of total cholesterol (TC), LDL cholesterol (LDL-chol), and apolipoprotein B (apo B). The combination of Lovastatin in dose of 40 mg with Colestipol in dose of 10 g decreased more favourably the concentrations of TC (34.7%), LDL-chol (44.3%), and apo B (22.4%) than administration of each of the drugs alone in higher doses i.e. Lovastatin 80 mg (TC--26.8%, LDL-chol--31.8%, apo B--16.9%) or Colestipol 20 g (TC -20.0%, LDL-chol-26.3%, apo B-10.8%). The treatment with Lovastatin and Colestipol failed to change significantly the concentrations of triglycerides, HDL cholesterol and AI and AII apolipoproteins. The combined therapy was better tolerated than monotherapy.
对20名患有高胆固醇血症或混合型高脂血症的男性患者,评估了洛伐他汀和考来烯胺联合用药及单独用药对脂蛋白的影响。联合用药或单独用药均显著降低了总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-胆固醇)和载脂蛋白B(apo B)的浓度。40毫克剂量的洛伐他汀与10克剂量的考来烯胺联合用药,相比单独使用更高剂量的每种药物,即80毫克洛伐他汀(TC降低26.8%,LDL-胆固醇降低31.8%,apo B降低16.9%)或20克考来烯胺(TC降低20.0%,LDL-胆固醇降低26.3%,apo B降低10.8%),能更有效地降低TC(34.7%)、LDL-胆固醇(44.3%)和apo B(22.4%)的浓度。洛伐他汀和考来烯胺治疗未能显著改变甘油三酯、高密度脂蛋白胆固醇以及A-I和A-II载脂蛋白的浓度。联合治疗比单一治疗耐受性更好。